Page

About HICORE Life Sciences

A UK-Based Peptide Research and Manufacturing Company

HICORE peptide lyophilized powder manufacturing facility

HICORE Life Sciences Limited is a UK-based biotechnology company focused on peptide research, lyophilized powder manufacturing and global B2B supply. We support biotechnology companies, research-material distributors, healthcare brands and international sourcing partners with product development, manufacturing coordination, quality documentation and OEM/ODM services.

Our operating model connects scientific research, production management and international customer support. This integrated approach enables us to respond to projects at different stages, from initial product discussions and sample evaluation to packaging development and volume manufacturing.

We aim to build long-term business relationships through clear communication, consistent production standards and practical manufacturing support. Our team works with customers to understand their technical requirements, target markets, expected order volumes and documentation needs before a project enters production.

15 Years of Peptide Manufacturing Experience

Lyophilization equipment for peptide powder manufacturing
Advanced GMP manufacturing facility for large-scale peptide lyophilized powder production and global OEM/ODM services.

HICORE has accumulated 15 years of experience in the production and supply of peptide-related products. This experience allows our team to understand the quality, consistency, documentation and delivery requirements that are important to international B2B customers.

Our services include peptide product research support, lyophilized powder manufacturing, production planning, private-label coordination, customized packaging and OEM/ODM project management. Depending on the project, we can support customers with product specifications, packaging formats, batch documentation and scalable manufacturing arrangements.

Whether a customer is developing a new product line, expanding an existing portfolio or looking for a more stable manufacturing partner, our team provides a structured process from requirement review to production and delivery.

We serve companies with different purchasing volumes and business models, including distributors, wholesalers, research suppliers and established brands. Every project is evaluated individually to ensure that the proposed production plan matches the customer’s actual requirements.

Manufacturing Capacity

Our manufacturing facility covers approximately 30,000 square metres and is equipped for the production of peptide-series lyophilized powder products. The facility includes dedicated production areas, manufacturing equipment, material-handling processes and quality-control procedures designed to support consistent batch production.

The factory operates five professional lyophilization production systems. Two large-scale systems have a stated production capacity of up to 120,000 vials per system per day, while three additional systems can produce up to 60,000 vials per system per day. Based on production planning, product specifications and batch requirements, the facility has a stated maximum daily output of approximately 400,000 vials.

This manufacturing capacity enables HICORE to support pilot orders, recurring supply programmes and larger-volume production projects. Actual output, lead time and batch size depend on product type, formulation, vial specification, testing requirements, packaging configuration and the confirmed production schedule.

Our production team reviews these factors before confirming a quotation or delivery plan, helping customers receive realistic manufacturing timelines rather than general estimates.

Research & Development

HICORE is supported by a nine-member research and technical team comprising postdoctoral researchers, PhD-qualified specialists and master’s-level researchers. The team focuses on peptide-related product research, manufacturing-process evaluation, formulation support, production monitoring and quality improvement.

Research and production personnel work together throughout the project cycle. Their responsibilities may include reviewing product requirements, evaluating process feasibility, supporting technical documentation, monitoring key production stages and assessing batch consistency.

This collaboration between research, manufacturing and quality personnel helps us identify technical risks early and establish more practical production plans. It also allows the company to support customers whose projects may require adjustments in formulation, packaging, production scale or quality documentation.

Our R&D approach is based on practical manufacturing requirements. Rather than separating scientific research from commercial production, we focus on converting technical requirements into scalable and repeatable manufacturing processes.

Quality and Compliance

HICORE’s biological R&D laboratory supports peptide innovation, formulation optimization and quality research.

Quality management is incorporated into material review, production preparation, in-process monitoring, finished-product assessment, documentation and batch release. The objective is to support product consistency, traceability and reliable documentation across the manufacturing process.

HICORE reports access to compliance and certification documentation associated with cGMP, NSF, ISO and Halal requirements, together with relevant FDA registration documentation and patent certificates. The exact certificate holder, issuing organization, validity period, applicable facility and product scope should be confirmed through the corresponding official document.

For this reason, customers are encouraged to request current copies of relevant certificates and registration records during supplier qualification. Available documents can be reviewed according to the requirements of the customer’s company and target market.

Batch-specific quality information should be confirmed through the applicable Certificate of Analysis and supporting documentation. Product specifications, testing items and results may vary by product and batch. HICORE does not recommend relying on general website statements as a replacement for released batch documentation.

Global B2B Partnerships

HICORE has supported more than 2,000 customers across over 50 countries and regions. Our customers include international distributors, sourcing companies, biotechnology businesses, research-product suppliers and private-label brands.

Some customer relationships have continued for several years, reflecting the importance of stable communication, dependable production planning and consistent supply. We understand that international buyers require more than a product quotation. They also need clear documentation, practical lead times, suitable packaging and responsive support before and after an order.

Our team works with customers in Europe, North America, the Middle East, Latin America, Australia and other international markets. Project arrangements are developed according to the customer’s order volume, documentation requirements, packaging preferences and destination market.

We welcome both established businesses and companies preparing to introduce a new product line. Each inquiry is reviewed individually so that manufacturing capability, quality requirements and commercial expectations can be discussed before cooperation begins.

Discuss Your Peptide Manufacturing Project

Looking for a peptide research-material supplier, lyophilized powder manufacturer or OEM/ODM production partner? Tell us about your product specifications, estimated order quantity, packaging requirements, target market and required documentation.

Our team will review your request and provide a practical response based on manufacturing feasibility, production scheduling and available quality documentation.

WhatsApp